TickerFactsScreenerDevelopers

Moleculin Biotech, Inc. (MBRX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2016: $21.0K2017: $28.0K2018: $417.0K2019: $52.0K2020: $376.0K2021: $19.0K2022: $67.0K2023: $124.0K2024: $13.0K2025: $0$0
2016Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$13.0K-89.5%
2023$124.0K+85.1%
2022$67.0K+252.6%
2021$19.0K-94.9%
2020$376.0K+623.1%
2019$52.0K-87.5%
2018$417.0K+1389.3%
2017$28.0K+33.3%
2016$21.0K—